TcrossGlobal

Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis: The SIBLINT-ISR Randomized Trial

The SIBLINT-ISR trial demonstrated that in the treatment of in-stent restenosis (ISR) of coronary arteries, the SeQuent sirolimus-coated balloon (SCB) was non-inferior to the SeQuent Please NEO paclitaxel-coated balloon (PCB), Dr. Haiwei Liu and colleagues, General Hospital of Northern Theater Command, China, reported in the April 28 issue of JACC: Cardiovascular Interventions.

In the SIBLINT-ISR trial, 258 patients (285 lesions) with coronary ISR lesions from 16 hospitals wer...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.